GLP-1 receptor agonists are revolutionizing obesity treatment but can cause significant muscle loss. Balancing weight loss with muscle preservation is crucial for overall health. Future research and strategic approaches, including nutrition and exercise, are essential. #Sarcopenia #MuscleHealth #GLP1 #WeightLoss
https://t.co/SWYPlDQBIF
The vocabulary of systems neuroscience may appear daunting to many. Here's a short dictionary of common terms. BTW if you use them in your papers and grants you will have greater success
Fun day to visit Shimadzu at their Kyoto headquarters. On the day that the Nobel Prize in Chemistry was awarded, here is reminder of the prize that Tanaka and Fenn were awarded in 2002. Along with a photo of one of the first commercial GC-MS instruments.
@LiverGALAXY and #MicrobLiver consortia meeting at #Bornholm
10 years focus on what today is named Steatotic Liver Disease👍
Large cohorts and omics🤓🧐 what can we learn?
Celebrating 🥳 @NatureMedicine paper https://t.co/4kx0nkhkAT
CMR in obese children- but modifiable!
An important study by F. Eun-Hyung Lee's team shows that long lived plasma cells (the source of long-term circulating antibodies) fail to establish after mRNA vaccination (even combined with SARS-CoV-2 infection). 🧵 (1/)
https://t.co/Z15xiyxCLS
A study in @NatureMedicine that included a lifestyle intervention program shows altered lipid profiles in children and adolescents with obesity and demonstrates that a personalized obesity management program can restore a healthy lipid profile. https://t.co/1jjGjtkMj8
As reported @NatureMedicine the authors demonstrate that lowering weight and improving health improves levels of dysregulated lipid species in children and adolescents with #overweight#obesity https://t.co/RDFp6a6Z3o
A combination of cross-sectional study and lifestyle intervention program uncovered altered lipid profiles in children and adolescents with obesity and demonstrated that a personalized obesity management program can restore a healthy lipid profile
https://t.co/aiCAqjARVu
"This has the potential to be an entirely new way to evaluate someone’s personal risk of disease..." - @DrLegidoQuigley principal author comments @guardian ⬇️
https://t.co/MuulZbPma8
Update fall 2024 for our international science team✨ & lab members over the years with “next career” which is usually pharma big & small or academia
https://t.co/auxNBZxAmt